News
The Latest Breakthroughs in Dental Treatments
Dental care has moved well beyond fillings and routine cleanings. In the past few years, the field has seen fast-moving advances across regenerative medicine, digital manufacturing, artificial intelligence (AI) and minimally invasive therapies. These breakthroughs promise better diagnostics, faster...
News
How Can Digital Tools Improve Medication Adherence in Patients?
Medication adherence has long been one of healthcare’s toughest challenges. Even the most effective treatment plan fails if patients don’t take their medications consistently. This isn’t just a patient-level problem, though; it has massive implications for healthcare systems, pharmaceutical...
BioPharma
Russia, Vietnam Collaborate on Biopharma Technology Transfer
Russia and Vietnam have gone on to officially formalize a major collaboration in healthcare, with Russia going ahead with the biopharma technology transfer to Vietnam.
It is well to be noted that this agreement was officially concluded at a signing...
Business & Industry
Trump Order to Go Heavy on D2C Pharmaceutical Ads
US President Donald Trump is all set to order his health department to go ahead and crack down on direct-to-consumer (D2C) pharmaceutical advertising as per a new memorandum that was inked on September 9, 2025.
This push, which happens to...
Business & Industry
Is US Planning Executive Order on Chinese Pharma Companies?
It is worth noting that the pharmaceutical sector’s recent source of novel molecules may as well be coming under threat. Apparently, it is the White House which is reportedly preparing an executive order that is going to place restrictions...
News
The Realities of the Nursing Shortage in Rural America
Along with multiple public health crises, the United States is also facing a nursing shortage, especially in rural parts of America. This problem is also exacerbated by rising costs, turnover, and competition in recruiting healthcare professionals. The factors contributing...
Health & Wellness
Green List by FDA to Cut Illegal GLP-1 Active Ingredients
The U.S. Food and Drug Administration has gone on to create a green list import alert in order to stop unapproved as well as unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering into the United States.
Because of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















